Search RXST
RxSight, Inc.
Nasdaq · CIK 1111485
Last close4.68
Daily change-0.07 (-1.47%)
10 Years gain-70.75%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
RXST · STANDARD
SIC 3851 · Ophthalmic Goods · Fiscal year end 1231
Fundamental
48.3Momentum
0.0Acceleration
0.0Confidence
81.0Annual Revenue6
Quarterly Revenue19
Annual CFO6
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth17.3 / 25
Quality18.7 / 25
Capital Efficiency3.9 / 20
Balance Sheet6.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 4.0193 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Operating margin compression · MEDIUMOperating margin compressed by 19.0467 percentage points.
Low interest coverage · HIGHInterest coverage is -3852x.
ROIC declining · MEDIUMROIC declined by 11.7515 percentage points.
Key Metrics
Revenue Growth TTM-11.26%OK
Revenue CAGR 3Y40%OK
Gross Margin75.59%OK
Operating Margin-47.32%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-68.89%OK
Incremental Operating Margin 3Y1.73%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y2.42%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $134.48M | $103.01M | -$48.19M | -$15.51M | -$19.34M | 76.6% | -35.84% | -14.38% | -83.15% | 40.85M |
| 2025 FY Dec 31, 2024 | $139.93M | $98.94M | -$36.86M | -$16.95M | -$22.39M | 70.71% | -26.34% | -16% | -75.44% | 38.87M |
| 2025 FY Dec 31, 2023 | $89.08M | $53.77M | -$50.09M | -$41.59M | -$46.41M | 60.36% | -56.23% | -52.1% | -137.75% | 34.46M |
| 2024 FY Dec 31, 2022 | $49.01M | $21.33M | -$63.32M | -$58.85M | -$61.24M | 43.52% | -129.21% | -124.97% | -232.99% | 27.66M |
| 2022 FY Dec 31, 2021 | $22.59M | $4.52M | -$52.79M | -$44.71M | -$46.65M | 19.99% | -233.64% | -206.47% | n/a | 13.63M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $122.11M | sum latest 4 fiscal quarters Revenue | OK | 0001193125-26-335153, 0001193125-25-266986 |
| Revenue Growth TTM | -11.26% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-26-335153, 0001193125-25-266986 |
| Revenue CAGR 3Y | 40% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-071775 |
| Revenue CAGR 5Y | 55.74% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-071775 |
| Gross Profit CAGR 3Y | 69.03% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-071775 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001193125-26-335153, 0001193125-25-266986 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 75.59% | Gross Profit / Revenue | OK | 0001193125-26-335153, 0001193125-25-266986 |
| Operating Margin | -47.32% | Operating Income / Revenue | OK | 0001193125-26-335153, 0001193125-25-266986 |
| ROIC | -68.89% | NOPAT / Average Invested Capital | OK | 0001193125-26-335153, 0001193125-25-266986 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-335153 |
| Interest Coverage | -3,852x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 4.07x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $2.94 | Revenue / Diluted Shares | OK | 0001193125-26-335153, 0001193125-25-266986 |